Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
14.49
+0.62 (4.47%)
At close: Jun 18, 2026, 4:00 PM EDT
14.12
-0.37 (-2.55%)
After-hours: Jun 18, 2026, 7:13 PM EDT
Generate Biomedicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $30 | Buy | Maintains | $30 | +107.04% | Jun 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +51.83% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $24 | Buy | Reiterates | $24 | +65.63% | May 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +72.53% | May 8, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $26 | Buy | Maintains | $26 | +79.43% | Apr 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 24, 2026 |